Dova Pharmaceuticals, Inc (DOVA) Covered Calls

Dova Pharmaceuticals, Inc., a pharmaceutical company, focuses on acquiring, developing, and commercializing drug candidates for thrombocytopenia disease. The company's lead drug candidate is avatrombopag that has completed Phase III clinical trials for the treatment of thrombocytopenia in patients with chronic liver disease. Dova Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Durham, North Carolina

You can sell covered calls on Dova Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for DOVA (prices last updated Thu 4:16 PM ET):

Dova Pharmaceuticals, Inc (DOVA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
7.46 -0.20 7.46 8.00 82K - 0.2B
Covered Calls For Dova Pharmaceuticals, Inc (DOVA)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Mar 15 7.5 0.50 7.50 0.0% 0.0%
Apr 18 7.5 0.80 7.20 4.2% 26.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial